LCN2 and liver cancer: Yao and coworkers show that the loss of leukemia inhibitory factor receptor in liver cancer activated NF-κB, which upregulates the iron-sequestering protein lipocalin-2 (LCN2), thereby decreasing ferroptosis sensitivity (Figure 2) (Yao et al., 2021).